File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: ASCI 2010 contrast media guideline for cardiac imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group

TitleASCI 2010 contrast media guideline for cardiac imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group
Authors
KeywordsMedicine & Public Health
Cardiology
Issue Date2010
PublisherSpringer Netherlands
Citation
The International Journal of Cardiovascular Imaging (formerly Cardiac Imaging), 2010, v. 26, p. 203-212 How to Cite?
AbstractThe use of contrast media for cardiac imaging becomes increasing as the widespread of cardiac CT and cardiac MR. A radiologist needs to carefully consider the indication and the injection protocol of contrast media to be used as well as the possibility of adverse effect. There are several guidelines for contrast media in western countries. However, these are focusing the adverse effect of contrast media. The Asian Society of Cardiovascular Imaging, the only society dedicated to cardiovascular imaging in Asia, formed a Working Group and created a guideline, which summarizes the integrated knowledge of contrast media for cardiac imaging. In cardiac imaging, coronary artery evaluation is feasible by non-contrast MR angiography, which can be an alternative examination in high risk patients for the use of iodine contrast media. Furthermore, the body habitus of Asian patients is usually smaller than that of their western counterparts. This necessitates modifications in the injection protocol and in the formula for calculation of estimated glomerular filtration rate. This guideline provided fundamental information for the use of contrast media for Asian patients in cardiac imaging. © 2010 The Author(s).
Persistent Identifierhttp://hdl.handle.net/10722/145031
ISSN
2015 Impact Factor: 1.88
2015 SCImago Journal Rankings: 0.858
ISI Accession Number ID
References

Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992 doi: 10.1053/j.ajkd.2008.12.034

Ma Y, Zuo L, Chen JH et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944 doi: 10.1681/ASN.2006040368

Fleischmann D, Kamaya A (2009) Optimal vascular and parenchymal contrast enhancement: the current state of the art. Radiol Clin North Am 47(1):13–26 doi: 10.1016/j.rcl.2008.10.009

Cademartiri F, van der Lugt A, Luccichenti G et al (2002) Parameters affecting bolus geometry in CTA: a review. J Comput Assist Tomogr 26(4):598–607 doi: 10.1097/00004728-200207000-00022

Becker CR, Hong C, Knez A et al (2003) Optimal contrast application for cardiac 4-detector-row computed tomography. Invest Radiol 38(11):690–694 doi: 10.1097/01.rli.0000084886.44676.e4

Cademartiri F, Mollet NR, Lemos PA et al (2006) Higher intracoronary attenuation improves diagnostic accuracy in MDCT coronary angiography. AJR Am J Roentgenol 187(4):W430–W433 doi: 10.2214/AJR.05.1406

Cademartiri F, Maffei E, Palumbo AA et al (2008) Influence of intra-coronary enhancement on diagnostic accuracy with 64-slice CT coronary angiography. Eur Radiol 18(3):576–583 doi: 10.1007/s00330-007-0773-0

Cademartiri F, Mollet NR, van der Lugt A et al (2005) Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation. Radiology 236(2):661–665 doi: 10.1148/radiol.2362040468

Rist C, Nikolaou K, Kirchin MA et al (2006) Contrast bolus optimization for cardiac 16-slice computed tomography: comparison of contrast medium formulations containing 300 and 400 milligrams of iodine per milliliter. Invest Radiol 41(5):460–467 doi: 10.1097/01.rli.0000208239.34723.5d

Tatsugami F, Kanamoto T, Nakai G et al (2010) Reduction of the total injection volume of contrast material with a short injection duration in 64-detector row CT coronary angiography. Br J Radiol 83(985):35–39 doi: 10.1259/bjr/23203690

Tatsugami F, Matsuki M, Inada Y et al (2010) Feasibility of low-volume injections of contrast material with a body weight-adapted iodine-dose protocol in 320-detector row coronary CT angiography. Acad Radiol 17(2):207–211 doi: 10.1016/j.acra.2009.09.010

Mitsumori LM, Wang E, May JM et al (2010) Triphasic contrast bolus for whole-chest ECG-gated 64-MDCT of patients with nonspecific chest pain: evaluation of arterial enhancement and streak artifact. AJR Am J Roentgenol 194(3):W263–W271 doi: 10.2214/AJR.09.2788

Litmanovich D, Zamboni GA, Hauser TH et al (2008) ECG-gated chest CT angiography with 64-MDCT and tri-phasic IV contrast administration regimen in patients with acute non-specific chest pain. Eur Radiol 18(2):308–317 doi: 10.1007/s00330-007-0739-2

Ishida M, Sakuma H, Murashima S et al (2009) Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: estimation from CT data. J Magn Reson Imag 29(1):205–210 doi: 10.1002/jmri.21470

Webb JA, Thomsen HS, Morcos SK (2005) Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15(6):1234–1240 doi: 10.1007/s00330-004-2583-y

Sakuma H, Ichikawa Y, Chino S et al (2006) Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 48(10):1946–1950 doi: 10.1016/j.jacc.2006.07.055

Wang CL, Cohan RH, Ellis JH et al (2007) Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69, 657 intravenous injections. Radiology 243(1):80–87 doi: 10.1148/radiol.2431060554

Dillman JR, Strouse PJ, Ellis JH et al (2007) Incidence and severity of acute allergic-like reactions to i.v nonionic iodinated contrast material in children. AJR Am J Roentgenol 188(6):1643–1647 doi: 10.2214/AJR.06.1328

Wang CL, Cohan RH, Ellis JH et al (2008) Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol 191(2):409–415 doi: 10.2214/AJR.07.3421

Herborn CU, Honold E, Wolf M et al (2007) Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest Radiol 42(1):58–62 doi: 10.1097/01.rli.0000248893.01067.e5

Bleicher AG, Kanal E (2008) Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. Am J Roentgenol 191(6):W307–W311 doi: 10.2214/AJR.07.3951

Christiansen C, Pichler WJ, Skotland T (2000) Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 10(12):1965–1975 doi: 10.1007/s003300000543

Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41 doi: 10.1159/000180580

Hafez T (2007) Modification of diet in renal disease (MDRD) estimated glomerular filtration rate (eGFR) formula. Am J Cardiol 99(4):584 doi: 10.1016/j.amjcard.2006.10.013

Solomon R, Werner C, Mann D et al (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331(21):1416–1420 doi: 10.1056/NEJM199411243312104

Solomon RJ, Natarajan MK, Doucet S et al (2007) Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115(25):3189–3196 doi: 10.1161/CIRCULATIONAHA.106.671644

Baker CS, Wragg A, Kumar S et al (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41(12):2114–2118 doi: 10.1016/S0735-1097(03)00487-X

Ferrario F, Barone MT, Landoni G et al (2009) Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy–a randomized controlled study. Nephrol Dial Transpl 24(10):3103–3107 doi: 10.1093/ndt/gfp306

Kanter MZ (2006) Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 63(19):1821–1827 doi: 10.2146/ajhp060050

Schweiger MJ, Chambers CE, Davidson CJ et al (2007) Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 69(1):135–140 doi: 10.1002/ccd.20964

Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transpl 21(4):1104–1108 doi: 10.1093/ndt/gfk062

Perazella MA (2009) Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol 4(2):461–469 doi: 10.2215/CJN.06011108

Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17(9):2359–2362 doi: 10.1681/ASN.2006060601

Prince MR, Zhang H, Morris M et al (2008) Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248(3):807–816 doi: 10.1148/radiol.2483071863

 

DC FieldValueLanguage
dc.contributor.authorASCI CCT & CMR Guideline Working Groupen_US
dc.contributor.authorJinzaki, Men_US
dc.contributor.authorKitagawa, Ken_US
dc.contributor.authorTsai, ICen_US
dc.contributor.authorChan, Cen_US
dc.contributor.authorYu, Wen_US
dc.contributor.authorYong, HSen_US
dc.contributor.authorChoi, BWen_US
dc.date.accessioned2012-02-21T05:42:56Z-
dc.date.available2012-02-21T05:42:56Z-
dc.date.issued2010en_US
dc.identifier.citationThe International Journal of Cardiovascular Imaging (formerly Cardiac Imaging), 2010, v. 26, p. 203-212en_US
dc.identifier.issn1569-5794en_US
dc.identifier.urihttp://hdl.handle.net/10722/145031-
dc.description.abstractThe use of contrast media for cardiac imaging becomes increasing as the widespread of cardiac CT and cardiac MR. A radiologist needs to carefully consider the indication and the injection protocol of contrast media to be used as well as the possibility of adverse effect. There are several guidelines for contrast media in western countries. However, these are focusing the adverse effect of contrast media. The Asian Society of Cardiovascular Imaging, the only society dedicated to cardiovascular imaging in Asia, formed a Working Group and created a guideline, which summarizes the integrated knowledge of contrast media for cardiac imaging. In cardiac imaging, coronary artery evaluation is feasible by non-contrast MR angiography, which can be an alternative examination in high risk patients for the use of iodine contrast media. Furthermore, the body habitus of Asian patients is usually smaller than that of their western counterparts. This necessitates modifications in the injection protocol and in the formula for calculation of estimated glomerular filtration rate. This guideline provided fundamental information for the use of contrast media for Asian patients in cardiac imaging. © 2010 The Author(s).en_US
dc.languageengen_US
dc.publisherSpringer Netherlandsen_US
dc.relation.ispartofThe International Journal of Cardiovascular Imaging (formerly Cardiac Imaging)en_US
dc.rightsThe Author(s)en_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong Licenseen_US
dc.subjectMedicine & Public Healthen_US
dc.subjectCardiologyen_US
dc.titleASCI 2010 contrast media guideline for cardiac imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working groupen_US
dc.typeArticleen_US
dc.identifier.openurlhttp://library.hku.hk:4551/resserv?sid=springerlink&genre=article&atitle=ASCI 2010 contrast media guideline for cardiac imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group&title=The International Journal of Cardiovascular Imaging (formerly Cardiac Imaging)&issn=15695794&date=2010-12-01&volume=26&issue=0& spage=203&authors=ASCI CCT & CMR Guideline Working Group, Masahiro Jinzaki, Kakuya Kitagawa, <i>et al.</i>en_US
dc.description.naturepublished_or_final_versionen_US
dc.identifier.doi10.1007/s10554-010-9691-3en_US
dc.identifier.pmid20931289-
dc.identifier.scopuseid_2-s2.0-78650511346en_US
dc.relation.referencesAmerican College of Radiology Manual on Contrast Media v7 http://www.acr.org/SecondaryMainMenuCategories/quality_safety/contrast_manual.aspxen_US
dc.relation.referencesESUR Guidelines on Contrast media (2006) Ver 6.0 http://www.esur.org/fileadmin/Guidelines/ESUR_2007_Guideline_6_Kern_Ubersicht.pdfen_US
dc.relation.referencesMatsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992en_US
dc.relation.referencesdoi: 10.1053/j.ajkd.2008.12.034en_US
dc.relation.referencesMa Y, Zuo L, Chen JH et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944en_US
dc.relation.referencesdoi: 10.1681/ASN.2006040368en_US
dc.relation.referencesFleischmann D, Kamaya A (2009) Optimal vascular and parenchymal contrast enhancement: the current state of the art. Radiol Clin North Am 47(1):13–26en_US
dc.relation.referencesdoi: 10.1016/j.rcl.2008.10.009en_US
dc.relation.referencesBae KT, Heiken JP, Brink JA (1998) Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate–pharmacokinetic analysis and experimental porcine model. Radiology 206(2):455–464en_US
dc.relation.referencesCademartiri F, van der Lugt A, Luccichenti G et al (2002) Parameters affecting bolus geometry in CTA: a review. J Comput Assist Tomogr 26(4):598–607en_US
dc.relation.referencesdoi: 10.1097/00004728-200207000-00022en_US
dc.relation.referencesBecker CR, Hong C, Knez A et al (2003) Optimal contrast application for cardiac 4-detector-row computed tomography. Invest Radiol 38(11):690–694en_US
dc.relation.referencesdoi: 10.1097/01.rli.0000084886.44676.e4en_US
dc.relation.referencesCademartiri F, Mollet NR, Lemos PA et al (2006) Higher intracoronary attenuation improves diagnostic accuracy in MDCT coronary angiography. AJR Am J Roentgenol 187(4):W430–W433en_US
dc.relation.referencesdoi: 10.2214/AJR.05.1406en_US
dc.relation.referencesCademartiri F, Maffei E, Palumbo AA et al (2008) Influence of intra-coronary enhancement on diagnostic accuracy with 64-slice CT coronary angiography. Eur Radiol 18(3):576–583en_US
dc.relation.referencesdoi: 10.1007/s00330-007-0773-0en_US
dc.relation.referencesCademartiri F, Mollet NR, van der Lugt A et al (2005) Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation. Radiology 236(2):661–665en_US
dc.relation.referencesdoi: 10.1148/radiol.2362040468en_US
dc.relation.referencesRist C, Nikolaou K, Kirchin MA et al (2006) Contrast bolus optimization for cardiac 16-slice computed tomography: comparison of contrast medium formulations containing 300 and 400 milligrams of iodine per milliliter. Invest Radiol 41(5):460–467en_US
dc.relation.referencesdoi: 10.1097/01.rli.0000208239.34723.5den_US
dc.relation.referencesFleischmann D, Rubin GD, Bankier AA et al (2000) Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography. Radiology 214(2):363–371en_US
dc.relation.referencesHaage P, Schmitz-Rode T, Hübner D et al (2000) Reduction of contrast material dose and artifacts by a saline flush using a double power injector in helical CT of the thorax. AJR Am J Roentgenol 174(4):1049–1053en_US
dc.relation.referencesTatsugami F, Kanamoto T, Nakai G et al (2010) Reduction of the total injection volume of contrast material with a short injection duration in 64-detector row CT coronary angiography. Br J Radiol 83(985):35–39en_US
dc.relation.referencesdoi: 10.1259/bjr/23203690en_US
dc.relation.referencesTatsugami F, Matsuki M, Inada Y et al (2010) Feasibility of low-volume injections of contrast material with a body weight-adapted iodine-dose protocol in 320-detector row coronary CT angiography. Acad Radiol 17(2):207–211en_US
dc.relation.referencesdoi: 10.1016/j.acra.2009.09.010en_US
dc.relation.referencesMitsumori LM, Wang E, May JM et al (2010) Triphasic contrast bolus for whole-chest ECG-gated 64-MDCT of patients with nonspecific chest pain: evaluation of arterial enhancement and streak artifact. AJR Am J Roentgenol 194(3):W263–W271en_US
dc.relation.referencesdoi: 10.2214/AJR.09.2788en_US
dc.relation.referencesLitmanovich D, Zamboni GA, Hauser TH et al (2008) ECG-gated chest CT angiography with 64-MDCT and tri-phasic IV contrast administration regimen in patients with acute non-specific chest pain. Eur Radiol 18(2):308–317en_US
dc.relation.referencesdoi: 10.1007/s00330-007-0739-2en_US
dc.relation.referencesIshida M, Sakuma H, Murashima S et al (2009) Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: estimation from CT data. J Magn Reson Imag 29(1):205–210en_US
dc.relation.referencesdoi: 10.1002/jmri.21470en_US
dc.relation.referencesWebb JA, Thomsen HS, Morcos SK (2005) Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15(6):1234–1240en_US
dc.relation.referencesdoi: 10.1007/s00330-004-2583-yen_US
dc.relation.referencesSakuma H, Ichikawa Y, Chino S et al (2006) Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 48(10):1946–1950en_US
dc.relation.referencesdoi: 10.1016/j.jacc.2006.07.055en_US
dc.relation.referencesYamaguchi K, Katayama H, Takashima T et al (1991) Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 178(2):363–367en_US
dc.relation.referencesLaroche D, Aimone-Gastin I, Dubois F et al (1998) Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 209(1):183–190en_US
dc.relation.referencesHopper KD, Houts PS, TenHave TR et al (1994) The effect of informed consent on the level of anxiety in patients given i.v. contrast material. AJR Am J Roentgenol 162(3):531–535en_US
dc.relation.referencesFederle MP, Chang PJ, Confer S et al (1998) Frequency and effects of ionic and nonionic CT contrast media during rapid bolus injection. Radiology 206(3):637–640en_US
dc.relation.referencesJacobs JE, Birnbaum BA, Langlotz CP (1998) Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology 209(2):411–416en_US
dc.relation.referencesWang CL, Cohan RH, Ellis JH et al (2007) Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69, 657 intravenous injections. Radiology 243(1):80–87en_US
dc.relation.referencesdoi: 10.1148/radiol.2431060554en_US
dc.relation.referencesCaro JJ, Trindade E, McGregor M (1991) The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. AJR Am J Roentgenol 156(4):825–832en_US
dc.relation.referencesBush WH, Swanson DP (1991) Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol 157(6):1153–1161en_US
dc.relation.referencesDillman JR, Strouse PJ, Ellis JH et al (2007) Incidence and severity of acute allergic-like reactions to i.v nonionic iodinated contrast material in children. AJR Am J Roentgenol 188(6):1643–1647en_US
dc.relation.referencesdoi: 10.2214/AJR.06.1328en_US
dc.relation.referencesKatayama H, Yamaguchi K, Kozuka T et al (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175(3):621–628en_US
dc.relation.referencesCochran ST, Bomyea K, Sayre JW (2001) Trends in adverse events after IV administration of contrast media. AJR Am J Roentgenol 176(6):1385–1388en_US
dc.relation.referencesWang CL, Cohan RH, Ellis JH et al (2008) Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol 191(2):409–415en_US
dc.relation.referencesdoi: 10.2214/AJR.07.3421en_US
dc.relation.referencesNelson KL, Gifford LM, Lauber-Huber C et al (1995) Clinical safety of gadopentetate dimeglumine. Radiology 196(2):439–443en_US
dc.relation.referencesHerborn CU, Honold E, Wolf M et al (2007) Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest Radiol 42(1):58–62en_US
dc.relation.referencesdoi: 10.1097/01.rli.0000248893.01067.e5en_US
dc.relation.referencesBleicher AG, Kanal E (2008) Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. Am J Roentgenol 191(6):W307–W311en_US
dc.relation.referencesdoi: 10.2214/AJR.07.3951en_US
dc.relation.referencesChristiansen C, Pichler WJ, Skotland T (2000) Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 10(12):1965–1975en_US
dc.relation.referencesdoi: 10.1007/s003300000543en_US
dc.relation.referencesBerkseth RO, Kjellstrand CM (1984) Radiologic contrast-induced nephropathy. Med Clin North Am 68(2):351–370en_US
dc.relation.referencesCruz C, Hricak H, Samhouri F et al (1986) Contrast media for angiography: effect on renal function. Radiology 158(1):109–112en_US
dc.relation.referencesCockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41en_US
dc.relation.referencesdoi: 10.1159/000180580en_US
dc.relation.referencesHafez T (2007) Modification of diet in renal disease (MDRD) estimated glomerular filtration rate (eGFR) formula. Am J Cardiol 99(4):584en_US
dc.relation.referencesdoi: 10.1016/j.amjcard.2006.10.013en_US
dc.relation.referencesSolomon R, Werner C, Mann D et al (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331(21):1416–1420en_US
dc.relation.referencesdoi: 10.1056/NEJM199411243312104en_US
dc.relation.referencesSolomon RJ, Natarajan MK, Doucet S et al (2007) Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115(25):3189–3196en_US
dc.relation.referencesdoi: 10.1161/CIRCULATIONAHA.106.671644en_US
dc.relation.referencesBaker CS, Wragg A, Kumar S et al (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41(12):2114–2118en_US
dc.relation.referencesdoi: 10.1016/S0735-1097(03)00487-Xen_US
dc.relation.referencesFerrario F, Barone MT, Landoni G et al (2009) Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy–a randomized controlled study. Nephrol Dial Transpl 24(10):3103–3107en_US
dc.relation.referencesdoi: 10.1093/ndt/gfp306en_US
dc.relation.referencesKanter MZ (2006) Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 63(19):1821–1827en_US
dc.relation.referencesdoi: 10.2146/ajhp060050en_US
dc.relation.referencesSchweiger MJ, Chambers CE, Davidson CJ et al (2007) Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 69(1):135–140en_US
dc.relation.referencesdoi: 10.1002/ccd.20964en_US
dc.relation.referencesYounathan CM, Kaude JV, Cook MD et al (1994) Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated with maintenance dialysis. AJR Am J Roentgenol 163(4):969–971en_US
dc.relation.referencesManufactuer’s Briefing Documents for FDA AdCom Meeting Dec (2009) http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/UCM183205.pdfen_US
dc.relation.referencesGrobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transpl 21(4):1104–1108en_US
dc.relation.referencesdoi: 10.1093/ndt/gfk062en_US
dc.relation.referencesPerazella MA (2009) Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol 4(2):461–469en_US
dc.relation.referencesdoi: 10.2215/CJN.06011108en_US
dc.relation.referencesMarckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17(9):2359–2362en_US
dc.relation.referencesdoi: 10.1681/ASN.2006060601en_US
dc.relation.referencesPrince MR, Zhang H, Morris M et al (2008) Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248(3):807–816en_US
dc.relation.referencesdoi: 10.1148/radiol.2483071863en_US
dc.relation.referencesLu JG, Lv B, Chen XB et al. (2009) What is the best contrast injection protocol for 64-row multi-detector cardiac computed tomography? Eur J Radiol [Epub ahead of print]en_US
dc.relation.referencesLee VS (2006) Cardiovascular MR imaging: physical principles to practical protocols. In: Lee VS (ed) Tissue characteristics and contrast agents: PD, T1 and T2, 1st edn. Lippincott Williams & Wilkins, Philadelphia, pp 42–50en_US
dc.identifier.volume26en_US
dc.identifier.spage203en_US
dc.identifier.epage212en_US
dc.identifier.eissn1573-0743en_US
dc.identifier.isiWOS:000284955200003-
dc.description.otherSpringer Open Choice, 21 Feb 2012en_US
dc.identifier.citeulike7973997-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats